Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 82
Filtrar
1.
Minerva Endocrinol ; 30(2): 95-9, 2005 Jun.
Artigo em Italiano | MEDLINE | ID: mdl-15988405

RESUMO

A 74 year-old man was admitted to the hospital for heart failure and atrial fibrillation episodes. He had been irregularly treated for hyperthyroidism during the previous 3 years, with poor control. Thyroid function evaluation showed secondary hyperthyroidism, with high free thyroid hormone levels and TSH inappropriately in the high-normal range (4.2 mU/ml), only slightly responsive to TRH-stimulation (6 microU/ml). Alpha-subunits were hyper-responsive to TRH stimulation (+123%). Thyroid autoimmunity tests were negative and ultrasonography evidenced a diffusely enlarged gland. Magnetic resonance (MR) imaging of the pituitary showed a macroadenoma. The patient underwent transphenoidal adenomectomy, and immunohistochemistry confirmed the diagnosis of a TSH-secreting pituitary macroadenoma. A moderate secondary hyperthyroidism was still present and a new MR evidenced residual disease, involving the right cavernous sinus. A (111)In-octreoscan revealed an increased captation in this area. The patient was treated with octreotide-Lar (20 mg/monthly), which normalized FT3, FT4 and TSH levels already after 3 months of therapy. This effect is still maintained at 42 months of treatment. MR imaging showed a reduction in the residual lesion after 18 months (>50% in comparison with postsurgical MR) and a further decrease after 36 months of treatment). This suggests that the antiproliferative effect on the adenomatous cells is progressive and continues over time. This patients did not receive radiotherapy, so this action is entirely due to the medical treatment. No significant side effects developed and the patient's compliance was good. He has not had further arrhythmic episodes.


Assuntos
Adenoma/tratamento farmacológico , Antineoplásicos Hormonais/uso terapêutico , Hipertireoidismo/tratamento farmacológico , Hipertireoidismo/etiologia , Octreotida/uso terapêutico , Neoplasias Hipofisárias/tratamento farmacológico , Tireotropina/metabolismo , Adenoma/sangue , Adenoma/diagnóstico , Adenoma/cirurgia , Idoso , Antineoplásicos Hormonais/administração & dosagem , Humanos , Hipertireoidismo/diagnóstico , Hipertireoidismo/cirurgia , Masculino , Octreotida/administração & dosagem , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/cirurgia , Hormônios Tireóideos/sangue , Resultado do Tratamento
2.
Am J Med Genet ; 47(6): 820-2, 1993 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-8279478

RESUMO

We describe an apparently newly recognized postnatal-onset obesity syndrome with short stature, mental deficiency, hypogonadism, micropenis, contractures of the fingers, and cleft lip-palate. Comparison is made with other postnatal-onset obesity syndromes, particularly Vasquez syndrome and Urban syndrome. The cause of our patient's syndrome is unknown at present. We encourage the reporting of other cases to help clarify whether our patient represents a separate entity.


Assuntos
Obesidade/genética , Adulto , Idade de Início , Estatura , Diagnóstico Diferencial , Feminino , Humanos , Deficiência Intelectual/genética , Masculino , Obesidade/classificação , Síndrome
3.
J Steroid Biochem Mol Biol ; 42(5): 547-54, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1616884

RESUMO

The purpose of our study was to evaluate the effects of 5 alpha-dihydrotestosterone (DHT) and hydroxyflutamide (HF), alone or in combination, on androgen receptor (AR) dynamics and on cellular growth in cultured breast cancer cells (EVSA-T). The incubation of cells with DHT increased the concentration of nuclear AR after 24 and 48 h. HF was also able to promote the nuclear accumulation of AR after 24 and 48 h of treatment. When HF-treated cells are incubated with DHT, the nuclear AR concentration is lower than that found in cells treated with DHT alone. We conclude that HF acts by increasing nuclear accumulation of receptor-antiandrogen complexes. Moreover, DHT stimulates cell growth while HF has an inhibitory effect. Thymidine incorporation in cells also increased after DHT treatment and decreased after HF incubation. The HF-induced inhibition of cell growth persisted both after renewal of the medium and after the addition of DHT to cultures. It may be hypothesized that either DHT is converted to inactive metabolites or that HF exerts a persistent inhibitory effect. In the latter case, the antiandrogen action of HF could be exerted by retention of high levels of antiandrogen in cells or by such a depressed protein synthesis that the renewal of growth is slower than the 48 h period studied.


Assuntos
Antagonistas de Androgênios/farmacologia , Neoplasias da Mama/patologia , Di-Hidrotestosterona/farmacologia , Flutamida/análogos & derivados , Receptores Androgênicos/efeitos dos fármacos , Neoplasias da Mama/metabolismo , Divisão Celular/efeitos dos fármacos , Flutamida/farmacologia , Humanos , Células Tumorais Cultivadas
4.
Metabolism ; 45(1): 72-5, 1996 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8544780

RESUMO

The influence of obesity on sex hormone-binding globulin (SHBG) and androgen concentrations in hirsute and nonhirsute women has been evaluated. The study was performed in 226 hirsute women (88 obese and 138 non-obese) classified as being affected by polycystic ovarian syndrome (PCOS) or by idiopathic hirsutism (IH) and in 100 nonhirsute control women ([C] 60 lean and 40 obese). SHBG, free testosterone (fT), androstenedione (A), estradiol (E2), dehydroepiandrosterone sulfate (DHEAS), and gonadotropin levels were measured during the first week of the menstrual cycle by radioimmunoassay (RIA). A significant negative correlation between SHBG and body mass index (BMI) was observed in PCOS, IH, and C women. In obese women--whether PCOS, IH, or C-fT levels were significantly higher and, conversely, SHBG levels were lower than in non-obese women. A negative correlation between SHBG and fT was evidenced in each group. Upper-body obesity was associated with lower SHBG and higher fT levels than lower-body obesity. In conclusion, obesity, particularly upper-body obesity, is associated with a reduction in SHBG and an increase in fT in both nonhirsute and hirsute women.


Assuntos
Hormônios Esteroides Gonadais/sangue , Hirsutismo/sangue , Obesidade/sangue , Globulina de Ligação a Hormônio Sexual/análise , Adolescente , Adulto , Androstenodiona/sangue , Índice de Massa Corporal , Desidroepiandrosterona/análogos & derivados , Desidroepiandrosterona/sangue , Sulfato de Desidroepiandrosterona , Estradiol/sangue , Feminino , Hirsutismo/complicações , Humanos , Obesidade/complicações , Síndrome do Ovário Policístico/sangue , Radioimunoensaio , Testosterona/sangue
5.
Anticancer Res ; 8(4): 819-23, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3178171

RESUMO

The role of PRL in human breast cancer is still debated. We examined 259 women undergoing surgery for breast cancer (K = 183) and for other diseases (n = 76). In all subjects blood samples were taken for the RIA assay of PRL, during the preanaesthesia. In the breast cancer specimens, estrogen (ER) and progesterone (PGR) receptors were assayed and T.N.M. was evaluated. PRL mean values were assayed and T.N.M. was evaluated. PRL mean values were found to be above the normal range in both groups. PRL values in ER+ and PGR+ were lower than in ER- and PGR-. We also divided the patients into two groups (PRL values greater than 50 or less than 50 ng/ml). The difference between the two groups was significant for ER (p less than 0.005) and PGR (p less than 0.05), using Student's unpaired t-test. Besides this, we observed a significant negative linear correlation between PRL values and receptor values. The finding of this correlation suggests that high PRL values could be associated with unfavourable prognosis in breast cancer.


Assuntos
Biomarcadores Tumorais/análise , Neoplasias da Mama/diagnóstico , Prolactina/sangue , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Biomarcadores Tumorais/sangue , Neoplasias da Mama/sangue , Feminino , Humanos , Menopausa , Prognóstico
6.
Anticancer Res ; 12(3): 705-8, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1622127

RESUMO

The aim of this study was to verify the presence of androgen receptors (AR) in human colorectal adenomas and in normal adjacent mucosa, and to determine whether there is any difference in AR tissue content between females and males. Our data show higher levels of nuclear AR in normal mucosa than in adenomas (p less than 0.001). A significant difference was also present in males between normal and pathological tissue both in cytosolic (p less than 0.05) and nuclear receptors (p less than 0.01). In female subjects this difference was also evident, but not significant. Our results seem to support the hypothesis of protective effects of androgens in colonic mucosa.


Assuntos
Adenoma/química , Núcleo Celular/química , Neoplasias Colorretais/química , Mucosa Intestinal/química , Receptores Androgênicos/análise , Adenoma/patologia , Núcleo Celular/ultraestrutura , Neoplasias Colorretais/patologia , Citosol/química , Citosol/ultraestrutura , Feminino , Humanos , Mucosa Intestinal/patologia , Masculino , Pessoa de Meia-Idade , Caracteres Sexuais
7.
Minerva Endocrinol ; 29(1): 25-9, 2004 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-15258555

RESUMO

The case of a 62-year-old woman with severe post-menopausal hirsutism is described. Her clinical history revealed regular menstrual periods until menopause at the age of 50, hysterectomy for fibromatosis at 58 years, non-insulin dependent diabetes mellitus, hypertension, obesity, severe hirsutism, which had developed in the previous 3 years, with a deeping of the voice. Examination showed android obesity, hypertension and severe hirsutism involving the face and the trunk. Endocrine evaluation pointed out regular adrenal function, serum total and free-testosterone in the adult male range, with normal androstenedione, DHEAS and 17OHP levels. Estradiol was slightly increased and LH and FSH were inappropriately low for her post-menopausal age. Computed tomography of the abdomen showed regular adrenal glands, and a radio-labeled cholesterol scan was negative. A further pelvic transvaginal ultrasonography revealed a small cystic formation near the right ovary and a slight increase in the size of the left ovary. The patient underwent bilateral ovariectomy. Histological examination showed a lipoid cell tumor within the left ovary. Immunohistochemical studies were positive for inhibin and cytokeratin. After surgery, serum testosterone fell to normal levels, gonadotropins increased to menopausal levels, confirming that the tumor was able to produce both LH, and FSH-inhibiting factors, and hirsutism greatly improved. Periodic hormonal tests remained normal and CT of the abdomen and pelvic ultrasonography did not show alterations at a 3 years follow-up.


Assuntos
Androgênios/metabolismo , Hirsutismo/etiologia , Neoplasias de Tecido Gonadal/complicações , Neoplasias Ovarianas/complicações , Virilismo/etiologia , Biomarcadores Tumorais/análise , Diabetes Mellitus Tipo 2/complicações , Estradiol/sangue , Feminino , Hormônio Foliculoestimulante/deficiência , Humanos , Hipertensão/complicações , Inibinas/análise , Queratinas/análise , Hormônio Luteinizante/deficiência , Pessoa de Meia-Idade , Neoplasias de Tecido Gonadal/química , Neoplasias de Tecido Gonadal/metabolismo , Neoplasias de Tecido Gonadal/cirurgia , Obesidade/complicações , Neoplasias Ovarianas/química , Neoplasias Ovarianas/metabolismo , Neoplasias Ovarianas/cirurgia , Ovariectomia
8.
Hepatogastroenterology ; 37(3): 345-9, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2373469

RESUMO

This study was conducted to assess the behavior of various parameters involved in mucosal protection (mucus and prostaglandins) and of presumed aggressive factors (hydrochloric acid and Helicobacter (Campylobacter) pylori in 20 patients with chronic liver disease, with or without clinical and instrumental signs of portal hypertension. The two groups of patients showed no difference from controls with respect to gastric acid secretion and the presence of antral Helicobacter pylori. The amount of gastric soluble mucus was reduced and the quality altered in cirrhotic patients with portal hypertension. The mucus of subjects with chronic active liver disease with no gross signs of portal hypertension showed significant qualitative differences from that of normal controls. The prostaglandin E2 concentration in the gastric mucosa was lower than normal in both groups of liver disease patients, but prostaglandin F2 alpha did not appear to differ between patients and controls.


Assuntos
Mucosa Gástrica/fisiologia , Hepatopatias/fisiopatologia , Prostaglandinas/fisiologia , Campylobacter/isolamento & purificação , Doença Crônica , Feminino , Ácido Gástrico/metabolismo , Mucosa Gástrica/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Muco/metabolismo
9.
Hepatogastroenterology ; 37(2): 208-11, 1990 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2341116

RESUMO

In the present study we evaluated the contents of endogenous prostaglandins type E2 and F2 alpha in the antral mucosa, and the type E2 in the duodenal mucosa in a group of thirty non-ulcer dyspeptics in comparison with a group of thirty duodenal ulcer patients. A significantly reduced concentration of duodenal and antral PGE2 was found in ulcer patients as compared with dyspeptic subjects. A significantly increased concentration of antral PGE2 was observed in cases with active superficial antral gastritis, either in dyspeptics or in duodenal ulcer patients, as compared with normal antrum cases. A significantly increased level of PGF2 alpha was found in active superficial gastritis of the dyspeptic group.


Assuntos
Dinoprosta/metabolismo , Dinoprostona/metabolismo , Úlcera Duodenal/metabolismo , Duodeno/metabolismo , Dispepsia/metabolismo , Mucosa Intestinal/metabolismo , Antro Pilórico/metabolismo , Adulto , Feminino , Ácido Gástrico/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade
10.
Recenti Prog Med ; 91(12): 636-40, 2000 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-11194482

RESUMO

Pituitary diseases are often unrecognized in the elderly, although if they can be at the basis of several pathological conditions. We report three clinical cases. Patient n. 1: 87 years old woman, in poor general condition. Thyroid function evaluation showed secondary hypothyroidism. Subsequent pituitary function evaluation demonstrated hypopituitarism with empty sella. The diagnosis was "hypopituitarism with secondary hypothyroidism and adrenocortical insufficiency, in empty sella" starting substitutive treatment with glucocorticoids and L-thyroxine, with improvement in her clinical conditions. Patient n. 2: 74 years old woman, with severe congestive heart failure. Her clinical history revealed hypothyroidism. An endocrine evaluation (in absence of therapy) demonstrated panhypopituitarism with secondary hypothyroidism and adrenocortical insufficiency in presence of empty sella. The patients was started on substitutive treatment and her conditions improved. Patient n. 3: 74 years old man with several atrial fibrillation episodes and hyperthyroidism. Thyroid function evaluation suggested secondary hyperthyroidism confirmed by the presence of a pituitary macroadenoma. The patient underwent surgical adenomectomy by trans-sphenoidal route. The clinical conditions of the patient improved, but a slight secondary hyperthyroidism was still present caused by the persistence of residual pathological tissue in the right cavernous sinus region confirmed by octreoscan suggesting the presence of a lesion endowed with somatostatin receptors. The patient was started on long acting octreotide treatment, which is still in progress. In conclusion, pituitary diseases pass often unrecognized in the elderly. Their prompt recognition and treatment can resolve dangerous situations for the patients.


Assuntos
Adenoma/diagnóstico , Hipotireoidismo/diagnóstico , Neoplasias Hipofisárias/diagnóstico , Adenoma/complicações , Adenoma/metabolismo , Hormônio Adrenocorticotrópico/sangue , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Feminino , Hormônio do Crescimento/sangue , Hormônios , Humanos , Hipotireoidismo/sangue , Hipotireoidismo/tratamento farmacológico , Imageamento por Ressonância Magnética , Octreotida , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/metabolismo , Tireotropina/sangue , Tomografia Computadorizada por Raios X
11.
Recenti Prog Med ; 92(12): 747-50, 2001 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-11822095

RESUMO

We report here the case of a patient with primary male ipogonadism, with small testes and deficient virilization of the external genitalia, but with 46XX, 45X0 karyotype. Hormonal determinations showed high LH and FSH and low testosterone levels. Ultrasonography confirmed the presence of small testes within the scrotum. Cytogenetic analysis demonstrated a female karyotype, with 90% 46XX, 10% 45X0 mosaicism. Using DNA probes for genes located on the Y chromosome, the presence of the "Sex-Determining Region" of the Y chromosome (SRY) was evidenced in the genomic DNA of this patient. By Fluorescence in Situ Hybridization (FISH), SRY locus was localized in the p terminal region of an X chromosome. SRY is the primary inducer of testis development; it acts as a transcription factor leading to a sequence of gene activations critical in the process of testicular differentiation and morphogenesis. A condition characterized by testicular development in subjects who lack a normal Y chromosome has been described; most of these patients are carriers of the short arm of the Y chromosome transferred to one of the two X chromosome, suggesting a form of X-Y paternal interchange. In our patient, the development of male gonade in the absence of an Y chromosome was explained by the demonstration of the SRY gene in an X chromosome.


Assuntos
Disgenesia Gonadal 46 XX , Hipogonadismo/genética , Síndrome de Turner , Idoso , Genótipo , Humanos , Hipogonadismo/diagnóstico , Hipogonadismo/metabolismo , Hibridização in Situ Fluorescente , Cariotipagem , Masculino , Mosaicismo , Fenótipo
18.
Andrologia ; 37(1): 36-9, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15644061

RESUMO

Among the various causes of gynaecomastia, testicular malignancies are an uncommon, life-threatening condition, which require prompt treatment. The case of a 26-year-old healthy man is described, who reported a 6-month painful bilateral gynaecomastia associated with secondary hypogonadism. Normal circulating 17beta-oestradiol (E2) levels showed an enhanced response to human chorionic gonadotrophin (hCG) testing, which led to a reduced testosterone (T)/E2 ratio. Both clinical and hormonal findings normalized following surgical exeresis of a left testicular mass, which proved to be a Leydig cell tumour (LCT) at histology. This report underlines the importance of ultrasonographic evaluation of the testes, whenever breast enlargement occurs in a healthy man, despite unremarkable findings on testicular examination. In addition, our case demonstrates that normal unstimulated circulating E2 levels do not allow the presence of a stromal testicular tumour to be ruled out and that the response of restored T levels to hCG testing can remain blunted up to 1 year after surgery. Finally, we claim that T/E2 ratio may be a useful tool in evaluating derangement of the endocrine milieu secondary to LCT.


Assuntos
Ginecomastia/etiologia , Tumor de Células de Leydig/complicações , Neoplasias Testiculares/complicações , Adulto , Gonadotropina Coriônica/sangue , Estradiol/sangue , Ginecomastia/fisiopatologia , Humanos , Tumor de Células de Leydig/fisiopatologia , Masculino , Neoplasias Testiculares/fisiopatologia
19.
J Endocrinol Invest ; 14(1): 31-5, 1991 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2045622

RESUMO

The purpose of this study was to determine the presence of cytosolic and nuclear androgen receptors (AR) in both normal and nodular thyroid tissues from twelve women and six men. Samples of benign thyroid nodules and corresponding surrounding normal tissue were processed by the single saturation point assay, using [3H] R1881 ([3H] Methyltrienolone) at final concentration of 5 nM. The results show the presence of AR (cytosolic and/or nuclear) in all examined tissue samples. The nuclear AR content was higher (p less than 0.01) in normal rather than in nodular thyroid tissues. The same pattern was observed when nuclear AR were analyzed according to the sex. In addition, nuclear AR content was significantly (p less than 0.05) higher in normal thyroid tissue from men than from women. Our data suggest an androgen influence on thyroid tissue. If androgens are supposed to exert an antagonist role on estrogen actions also in thyroid tissue, the presence of higher nuclear AR concentration in the male rather than in the female normal thyroid may justify the lower incidence of thyroid diseases in men. Moreover, the lower AR levels found in male as well as in female nodular and goitrous tissues support the hypothesis that androgens may act with an antagonist mechanism on thyroid growth.


Assuntos
Receptores Androgênicos/metabolismo , Doenças da Glândula Tireoide/metabolismo , Glândula Tireoide/metabolismo , Adulto , Idoso , Núcleo Celular/metabolismo , Núcleo Celular/ultraestrutura , Citosol/metabolismo , Citosol/ultraestrutura , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Receptores Androgênicos/análise , Caracteres Sexuais , Doenças da Glândula Tireoide/patologia , Glândula Tireoide/ultraestrutura
20.
Horm Metab Res ; 9(6): 492-4, 1977 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-590923

RESUMO

Prolactin (PRL) secretion was studied after i.m. administration of Metoclopramide (alone or with a pretreatment with 5-Br-2alpha-ergo-cryptine) and after i.m. administration of Sulpiride. The results obtained evidenced a considerable hPRL increase after Metoclopramide administration, similar to that observed with Sulpiride, completely abolished by 5-Br-2alpha-ergocryptine. On the basis of these data it seems evident a strong and specific effect of Metoclopramide on hPRL secretion, probably more potent than Sulpiride.


Assuntos
Metoclopramida/farmacologia , Prolactina/metabolismo , Adolescente , Adulto , Idoso , Bromocriptina/farmacologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Sulpirida/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA